Breaking
FDA requires new vision loss warning for GLP-1 drugsCompass Files FDA NDA for Psilocybin Depression TreatmentPROTAC drugs face major formulation hurdlesAI-designed TEAD inhibitor shows tumor shrinkageHepatitis C drug shows promise but misses key patient groupsModerna Merck seek approval for melanoma vaccine

vision loss

FDA requires new vision loss warning for GLP-1 drugs
Body Signals

FDA requires new vision loss warning for GLP-1 drugs

The FDA requires a new warning about vision loss for GLP-1 drugs after a review of clinical trials and case reports.

Zoe Cooper · November 13, 2026